AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
Log in

OTCMKTS:TRSSFTerrascend Stock Price, Forecast & News

$2.17
+0.10 (+4.82 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.11
Now: $2.17
$2.26
50-Day Range
$1.92
MA: $2.20
$2.49
52-Week Range
$1.19
Now: $2.17
$5.37
Volume63,800 shs
Average Volume86,255 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TerrAscend Corp., a biopharmaceutical and wellness company, engages in the cultivation, development, and sale of medical cannabis in Canada. The company offers its cannabis products under the Knüba Naturals brand. It also provides education and support programs to physicians and patients through health care professionals. The company was incorporated in 2017 and is based in Mississauga, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.82 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRSSF
CUSIPN/A
CIKN/A
Phone855-837-7295

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive TRSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for TRSSF and its competitors with MarketBeat's FREE daily newsletter.

Terrascend (OTCMKTS:TRSSF) Frequently Asked Questions

How has Terrascend's stock been impacted by COVID-19 (Coronavirus)?

Terrascend's stock was trading at $1.8277 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRSSF shares have increased by 18.9% and is now trading at $2.1730. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Terrascend?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terrascend in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Terrascend.

Has Terrascend been receiving favorable news coverage?

News headlines about TRSSF stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Terrascend earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news about Terrascend.

Who are some of Terrascend's key competitors?

Who are Terrascend's key executives?

Terrascend's management team includes the following people:
  • Dr. Michael Nashat, Founder, CEO, COO & Director (Age 35)
  • Mr. Matthew J. Johnson, Pres
  • Mr. Adam Kozak, Chief Financial Officer
  • Mr. Alex Correia, VP of Corp. Affairs & Communications
  • Ms. Dawn Vanek-Mithra, Director of Marketing

What is Terrascend's stock symbol?

Terrascend trades on the OTCMKTS under the ticker symbol "TRSSF."

How do I buy shares of Terrascend?

Shares of TRSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Terrascend's stock price today?

One share of TRSSF stock can currently be purchased for approximately $2.17.

What is Terrascend's official website?

The official website for Terrascend is www.terrascend.com.

How can I contact Terrascend?

The company can be reached via phone at 855-837-7295.

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.